Yusuf Erkul is co-founder and CEO of Kernal Biologics, a biotech company focused on messenger RNA immunotherapy. He previously worked at Merck on oncology drug discovery and development, holds an M.D. from Hacettepe University, a B.S. in Biology from MIT, and an executive MBA from MIT Sloan.
Intro paths
YC
Yusuf went through Y Combinator (Summer 2020) — any YC alum in your network can reach them through the YC community.
GP
Their group partner at YC was Jared Friedman, General Partner at Y Combinator — the partner who ran Kernal Biologics's batch and knows the company first-hand. YC profile ↗
→
In turn, Yusuf can intro founders to Kernal Biologics's investors below.
Kernal Biologics's investors · 7
Co-founders
JO
Jeff OzdemirFounder
BY
Burak YilmazFounder
BY
Burak YILMAZFounder
CM
Catherine MoroskiExecutive Officer, Director
OY
Oguzhan YilmasDirector